Compounds > ethacrynic acid

ethacrynic acid and ciclopirox

ethacrynic acid has been researched along with ciclopirox in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's6 (85.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Carson, D; Endo, T; Lu, D; Schmidt, M; Schmidt-Wolf, IG; Sievers, E1
Kim, Y; Koller, CM; Schmidt-Wolf, IG1
Endo, T; Kim, Y; Lu, D; Schmeel, FC; Schmeel, LC; Schmidt-Wolf, IG1
Schmeel, FC; Schmeel, LC; Schmidt-Wolf, IG; Von Schulz-Hausmann, SA1
Schmidt-Wolf, IG; Wall, I1
Messina, CS; Schmidt-Wolf, IG; Weiher, H1

Other Studies

7 other study(ies) available for ethacrynic acid and ciclopirox

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Targeting Wnt pathway in lymphoma and myeloma cells.
    British journal of haematology, 2009, Volume: 144, Issue:5

    Topics: Antifungal Agents; Apoptosis; Cell Line, Tumor; Ciclopirox; Diuretics; Ethacrynic Acid; Humans; Lymphoma; Multiple Myeloma; Pyridones; Signal Transduction; Wnt Proteins

2009
Targeting renal cancer with a combination of WNT inhibitors and a bi-functional peptide.
    Anticancer research, 2013, Volume: 33, Issue:6

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cell Survival; Ciclopirox; Drug Combinations; Ethacrynic Acid; Ethanolamines; Humans; Kidney Neoplasms; Oligopeptides; Peptides; Protein Structure, Tertiary; Pyridones; Wnt Proteins

2013
Targeting the Wnt/beta-catenin pathway in multiple myeloma.
    Anticancer research, 2013, Volume: 33, Issue:11

    Topics: Animals; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; beta Catenin; Blotting, Western; Cell Proliferation; Cells, Cultured; Ciclopirox; Colon; Diuretics; Drug Synergism; Ethacrynic Acid; Flow Cytometry; Humans; Mice; Multiple Myeloma; Protein-Tyrosine Kinases; Pyridones; Stilbenes; Wnt Proteins

2013
Targeting the Wnt/beta-catenin pathway in renal cell carcinoma.
    Anticancer research, 2014, Volume: 34, Issue:8

    Topics: beta Catenin; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Ciclopirox; Drug Combinations; Ethacrynic Acid; Ethanolamines; Humans; Kidney Neoplasms; Pyridones; Wnt Signaling Pathway

2014
Effect of Wnt inhibitors in pancreatic cancer.
    Anticancer research, 2014, Volume: 34, Issue:10

    Topics: Antineoplastic Agents; Cell Line, Tumor; Ciclopirox; Drug Combinations; Ethacrynic Acid; Ethanolamines; Griseofulvin; Humans; Pancreatic Neoplasms; Pyridones; Wnt Proteins; Wnt Signaling Pathway

2014
Targeting Prostate Cancer with a Combination of WNT Inhibitors and a Bi-functional Peptide.
    Anticancer research, 2017, Volume: 37, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Ciclopirox; Drug Synergism; Ethacrynic Acid; Humans; Intercellular Signaling Peptides and Proteins; Male; Molecular Targeted Therapy; Oligopeptides; Peptides; Prostatic Neoplasms; Protein Domains; Pyridones; Wnt Proteins

2017